Cargando…

Physiologically based pharmacokinetic-quantitative systems toxicology and safety (PBPK-QSTS) modeling approach applied to predict the variability of amitriptyline pharmacokinetics and cardiac safety in populations and in individuals

The physiologically based pharmacokinetic (PBPK) models allow for predictive assessment of variability in population of interest. One of the future application of PBPK modeling is in the field of precision dosing and personalized medicine. The aim of the study was to develop PBPK model for amitripty...

Descripción completa

Detalles Bibliográficos
Autores principales: Tylutki, Zofia, Mendyk, Aleksander, Polak, Sebastian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6182726/
https://www.ncbi.nlm.nih.gov/pubmed/29943290
http://dx.doi.org/10.1007/s10928-018-9597-6
_version_ 1783362633020211200
author Tylutki, Zofia
Mendyk, Aleksander
Polak, Sebastian
author_facet Tylutki, Zofia
Mendyk, Aleksander
Polak, Sebastian
author_sort Tylutki, Zofia
collection PubMed
description The physiologically based pharmacokinetic (PBPK) models allow for predictive assessment of variability in population of interest. One of the future application of PBPK modeling is in the field of precision dosing and personalized medicine. The aim of the study was to develop PBPK model for amitriptyline given orally, predict the variability of cardiac concentrations of amitriptyline and its main metabolite—nortriptyline in populations as well as individuals, and simulate the influence of those xenobiotics in therapeutic and supratherapeutic concentrations on human electrophysiology. The cardiac effect with regard to QT and RR interval lengths was assessed. The Emax model to describe the relationship between amitriptyline concentration and heart rate (RR) length was proposed. The developed PBPK model was used to mimic 29 clinical trials and 19 cases of amitriptyline intoxication. Three clinical trials and 18 cases were simulated with the use of PBPK-QSTS approach, confirming lack of cardiotoxic effect of amitriptyline in therapeutic doses and the increase in heart rate along with potential for arrhythmia development in case of amitriptyline overdose. The results of our study support the validity and feasibility of the PBPK-QSTS modeling development for personalized medicine. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s10928-018-9597-6) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6182726
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-61827262018-10-24 Physiologically based pharmacokinetic-quantitative systems toxicology and safety (PBPK-QSTS) modeling approach applied to predict the variability of amitriptyline pharmacokinetics and cardiac safety in populations and in individuals Tylutki, Zofia Mendyk, Aleksander Polak, Sebastian J Pharmacokinet Pharmacodyn Original Paper The physiologically based pharmacokinetic (PBPK) models allow for predictive assessment of variability in population of interest. One of the future application of PBPK modeling is in the field of precision dosing and personalized medicine. The aim of the study was to develop PBPK model for amitriptyline given orally, predict the variability of cardiac concentrations of amitriptyline and its main metabolite—nortriptyline in populations as well as individuals, and simulate the influence of those xenobiotics in therapeutic and supratherapeutic concentrations on human electrophysiology. The cardiac effect with regard to QT and RR interval lengths was assessed. The Emax model to describe the relationship between amitriptyline concentration and heart rate (RR) length was proposed. The developed PBPK model was used to mimic 29 clinical trials and 19 cases of amitriptyline intoxication. Three clinical trials and 18 cases were simulated with the use of PBPK-QSTS approach, confirming lack of cardiotoxic effect of amitriptyline in therapeutic doses and the increase in heart rate along with potential for arrhythmia development in case of amitriptyline overdose. The results of our study support the validity and feasibility of the PBPK-QSTS modeling development for personalized medicine. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s10928-018-9597-6) contains supplementary material, which is available to authorized users. Springer US 2018-06-25 2018 /pmc/articles/PMC6182726/ /pubmed/29943290 http://dx.doi.org/10.1007/s10928-018-9597-6 Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Original Paper
Tylutki, Zofia
Mendyk, Aleksander
Polak, Sebastian
Physiologically based pharmacokinetic-quantitative systems toxicology and safety (PBPK-QSTS) modeling approach applied to predict the variability of amitriptyline pharmacokinetics and cardiac safety in populations and in individuals
title Physiologically based pharmacokinetic-quantitative systems toxicology and safety (PBPK-QSTS) modeling approach applied to predict the variability of amitriptyline pharmacokinetics and cardiac safety in populations and in individuals
title_full Physiologically based pharmacokinetic-quantitative systems toxicology and safety (PBPK-QSTS) modeling approach applied to predict the variability of amitriptyline pharmacokinetics and cardiac safety in populations and in individuals
title_fullStr Physiologically based pharmacokinetic-quantitative systems toxicology and safety (PBPK-QSTS) modeling approach applied to predict the variability of amitriptyline pharmacokinetics and cardiac safety in populations and in individuals
title_full_unstemmed Physiologically based pharmacokinetic-quantitative systems toxicology and safety (PBPK-QSTS) modeling approach applied to predict the variability of amitriptyline pharmacokinetics and cardiac safety in populations and in individuals
title_short Physiologically based pharmacokinetic-quantitative systems toxicology and safety (PBPK-QSTS) modeling approach applied to predict the variability of amitriptyline pharmacokinetics and cardiac safety in populations and in individuals
title_sort physiologically based pharmacokinetic-quantitative systems toxicology and safety (pbpk-qsts) modeling approach applied to predict the variability of amitriptyline pharmacokinetics and cardiac safety in populations and in individuals
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6182726/
https://www.ncbi.nlm.nih.gov/pubmed/29943290
http://dx.doi.org/10.1007/s10928-018-9597-6
work_keys_str_mv AT tylutkizofia physiologicallybasedpharmacokineticquantitativesystemstoxicologyandsafetypbpkqstsmodelingapproachappliedtopredictthevariabilityofamitriptylinepharmacokineticsandcardiacsafetyinpopulationsandinindividuals
AT mendykaleksander physiologicallybasedpharmacokineticquantitativesystemstoxicologyandsafetypbpkqstsmodelingapproachappliedtopredictthevariabilityofamitriptylinepharmacokineticsandcardiacsafetyinpopulationsandinindividuals
AT polaksebastian physiologicallybasedpharmacokineticquantitativesystemstoxicologyandsafetypbpkqstsmodelingapproachappliedtopredictthevariabilityofamitriptylinepharmacokineticsandcardiacsafetyinpopulationsandinindividuals